TGFB1 and myocardial infarction: For example, by treating human mesenchymal progenitor cells and human cardiac dECM with transforming growth factor beta (TGF-β), Godier-Furnémont et al. produced composite scaffold that promoted the formation of vascular networks when used to treat injured heart using a rat MI model, leading to functional recovery of left ventricular systolic dimensions and contractile properties [105].